Platinum distribution inintraperitoneal tumors afterintraperitoneal cisplatin treatment Gerrit LosPeter H. A. MutsaersJ. Gordon McVie Original Articles Pages: 389 - 394
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP Brenda J. FosterBonnie J. HardingBrian Leyland-Jones Original Articles Pages: 395 - 404
Modification of methyliminodiacetato-trans-R, R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody Michael G. RosenblumJames L. MurrayAbdul R. Khokhar Original Articles Pages: 405 - 410
Metallothionein-like proteins and cell resistance tocis-dichlorodiammineplatinum(II) in L1210 cells Paul FarnworthBrian HillcoatIan Roos Original Articles Pages: 411 - 417
The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology Li-Ming WangJ. Courtland WhiteRobert L. Capizzi Original Articles Pages: 418 - 424
Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo Steadman D. Harrison Jr.Jacqueline PlowmanDaniel P. Griswold Jr. Original Articles Pages: 425 - 429
DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and-resistant human colon carcinoma cells Laura CapolongoGiorgio BelvedereMaurizio D'Incalci Original Articles Pages: 430 - 434
Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer Miguel H. BronchudJennifer M. MargisonPeter M. Wilkinson Original Articles Pages: 435 - 439
Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid Andreas SchalhornMichael KühlVolkmar Nüssler Original Articles Pages: 440 - 444
Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients Luisa ZanetteMassimo ZucchettiMaurizio D'Incalci Original Articles Pages: 445 - 448
Ondansetron — a new safe and effective antiemetic in patients receiving high-dose melphalan C. V. VinerP. J. SelbyT. J. McElwain Original Articles Pages: 449 - 453
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside Saeeda KirmaniSolomon ZimmStephen B. Howell Original Articles Pages: 454 - 458
Toxicity of intra-arterial doxorubicin in locally advanced breast cancer Christopher J. TwelvesMurid A. ChaudaryRobert D. Rubens Short Communication Pages: 459 - 462
Phase II study of teniposide in advanced breast cancer Janne BoasDorte RasmussenPer Dombernowsky Short Communication Pages: 463 - 464
